Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Zymeworks Inc ZYME

Healthcare Biotechnology
Zymeworks Inc. is a global biotechnology company. The Company is engaged in the discovery, development, and commercialization of multifunctional biotherapeutics to treat cancer and other serious diseases. Its complementary therapeutic platforms and fully integrated drug development engine provide the flexibility and compatibility to precisely engineer and develop differentiated antibody-based... see more

NDAQ:ZYME - Post Discussion

Zymeworks Inc > What is management doing?
View:
Post by Gringotts on Nov 11, 2021 3:59pm

What is management doing?

At this rate of share price decline, ZYME will be a penny stock within months. What the he ll is management doing to help support the stock. If the next read-out is poor ZYME will be decimated. 

Who is the clown that gave ZYME a $74.00 price target with a strong buy. Raymond James should fire him.
Comment by ghayes on Nov 13, 2021 1:29pm
see friday trades.,   not much doing all morning,  dropped down to 18.96 at the bottom. then suddenly at 1pm it climbed up a dollar to 20.00+ within the hour. the market makers playing their usual shake-out then re-stabilise games. nothing has changed with the company or the product.   This is a longer term play. The package they are creatingm a clinically tested ...more  
Zymeworks Inc